Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment of HIV-1 in Appropriate Patients
.
Show all posts
Showing posts with label
Treatment of HIV-1 in Appropriate Patients
.
Show all posts
Saturday, November 17, 2018
FDA Approves Merck’s Pifeltro (doravirine) for the Treatment of HIV-1 in Appropriate Patients
›
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (...
Thursday, November 15, 2018
FDA Approves Merck’s Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) for the Treatment of HIV-1 in Appropriate Patients
›
In continuation of my update on Lamivudine and Tenofovir doravirine Lamivudine ...
›
Home
View web version
